Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients

被引:0
作者
Adrien Zanin
Guy Amah
Sahar Chakroun
Pauline Testard
Alice Faucher
Thi Yen Vy Le
Dorsaf Slama
Valérie Le Baut
Pierre Lozeron
Dominique Salmon
Nathalie Kubis
机构
[1] Université Paris Cité,INSERM UMR1144
[2] Université Paris Cité,Service de Physiologie Clinique – Explorations Fonctionnelles, AP
[3] Université Paris Cité,HP, DMU DREAM, Hôpital Lariboisière
[4] Hôpital Lariboisière,Department of Immunology and Infectious Diseases, APHP, Cochin
来源
Scientific Reports | / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Several disabling symptoms potentially related to dysautonomia have been reported in “long-COVID” patients. Unfortunately, these symptoms are often nonspecific, and autonomic nervous system explorations are rarely performed in these patients. This study aimed to evaluate prospectively a cohort of long-COVID patients presenting severe disabling and non-relapsing symptoms of potential dysautonomia and to identify sensitive tests. Autonomic function was assessed by clinical examination, the Schirmer test; sudomotor evaluation, orthostatic blood pressure (BP) variation, 24-h ambulatory BP monitoring for sympathetic evaluation, and heart rate variation during orthostatism, deep breathing and Valsalva maneuvers for parasympathetic evaluation. Test results were considered abnormal if they reached the lower thresholds defined in publications and in our department. We also compared mean values for autonomic function tests between patients and age-matched controls. Sixteen patients (median age 37 years [31–43 years], 15 women) were included in this study and referred 14.5 months (median) [12.0–16.5 months] after initial infection. Nine had at least one positive SARS-CoV-2 RT-PCR or serology result. Symptoms after SARS-CoV-2 infection were severe, fluctuating and disabling with effort intolerance. Six patients (37.5%) had one or several abnormal test results, affecting the parasympathetic cardiac function in five of them (31%). Mean Valsalva score was significantly lower in patients than in controls. In this cohort of severely disabled long-COVID patients, 37.5% of them had at least one abnormal test result showing a possible contribution of dysautonomia to these nonspecific symptoms. Interestingly, mean values of the Valsalva test were significantly lower in patients than in control subjects, suggesting that normal values thresholds might not be appropriate in this population.
引用
收藏
相关论文
共 157 条
  • [1] Soriano JB(2022)A clinical case definition of post-COVID-19 condition by a Delphi consensus Lancet Infect. Dis. 22 e102-e107
  • [2] Murthy S(2021)COVID-19 dysautonomia Front. Neurol. 12 624968-e67
  • [3] Marshall JC(2021)Autonomic dysfunction in “long COVID”: Rationale, physiology and management strategies Clin. Med. (Lond.) 21 e63-211
  • [4] Goodman BP(2021)Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: A case series of 20 patients Immunol. Res. 69 205-368
  • [5] Khoury JA(2021)Long-COVID postural tachycardia syndrome: An American Autonomic Society statement Clin. Auton. Res. 31 365-270
  • [6] Blair JE(2020)Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment Prog. Cardiovasc. Dis. 63 263-394
  • [7] Grill MF(2021)Autonomic dysfunction following COVID-19 infection: An early experience Clin. Auton. Res. 31 385-443
  • [8] Dani M(2022)Small fiber neuropathy associated with SARS-CoV-2 infection Muscle Nerve 65 440-752
  • [9] Dirksen A(2021)Instrumental evaluation of COVID-19 related dysautonomia in non-critically-ill patients: An observational, cross-sectional study J. Clin. Med. 10 5861-17
  • [10] Taraborrelli P(2021)Clinical characterization of dysautonomia in long COVID-19 patients Sci. Rep. 11 14042-370